Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Total Non-Current Liabilities (2016 - 2025)

Ingevity (NGVT) has disclosed Total Non-Current Liabilities for 11 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 6.83% to $1.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 6.83% decrease, with the full-year FY2025 number at $1.6 billion, down 6.83% from a year prior.
  • Total Non-Current Liabilities was $1.6 billion for Q4 2025 at Ingevity, down from $1.7 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.0 billion in Q2 2023 to a low of $1.6 billion in Q4 2025.
  • A 5-year average of $1.8 billion and a median of $1.7 billion in 2024 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: dropped 26.34% in 2021, then grew 25.33% in 2023.
  • Ingevity's Total Non-Current Liabilities stood at $1.7 billion in 2021, then grew by 15.19% to $1.9 billion in 2022, then fell by 3.02% to $1.9 billion in 2023, then fell by 9.03% to $1.7 billion in 2024, then decreased by 6.83% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Total Non-Current Liabilities are $1.6 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.7 billion (Q2 2025).